Schneider Children's Medical Center of Israel
Petah Tikva, 49202, Israel
NCT Number: NCT03663309
To assess the adherence to gluten free diet by measuring faecal and urinary gluten immunogenic peptides (GIP). This will provide an objective measure for adherence.
Looking for future studies?
Notify Me2 year–17 year
All sexes
Observational
Petah Tikva, 49202, Israel
The adherence to the GFD can be assessed through a dietary interview performed by a registered dietitian or patient self-reports, mucosal healing, assessed by a small bowel biopsy or CD serological screening tests showing decreasing levels of antibodies. However, none of these methods offer an accurate measure of dietary compliance. A novel method to monitor the adherence to the GFD by detection of immune-dominant gluten peptides in human faeces or urine using the anti-α -gliadin G12 antibody was described recently in the literature. Gluten peptides, in particular peptides equivalent to the immunogenic - α -gliadin-33-mer peptide, are resistant to gastrointestinal digestion and that ensures a significant amount of the ingested gluten is excreted in faeces. Consequently, recovery of detectable amounts of the immunogenic fraction in faeces or urine indicates that gluten has passed through the digestive tract, and in the case of urine was absorbed, and, therefore, that gluten has been consumed .
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
° Children with suspected or known inflammatory bowel disease or other gastrointestinal or systemic diseases.
At each visit patient will:
Time frame: one year
Our goal is to examine which method will be the most accurate, nutritional assessment or laboratory tests for the adherence to GFD
Rabin Medical Center
Other
Assessment of Adherence to Gluten Free Diet in Children and Adolescents by Detection of Gluten Immunogenic Peptides in Faecal Samples and Nutritional Assessment. Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06038344
Adherence, Treatment, Behavior
Edmonton, Alberta, Canada
View Trial DetailsNCT04014660
Autoimmune Diseases, Celiac Disease in Children
Malmö, Sweden
View Trial DetailsNCT07436884
Celiac Disease in Children, Nutrition, Healthy
Vitoria-Gasteiz, Alava, Spain
View Trial DetailsNCT06783673
Celiac Disease in Children
Sohag, Sohag Governorate, Egypt
View Trial Details